Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder f…
Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Satsuma Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDSatsuma Pharmaceuticals, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Satsuma Pharmaceuticals, Inc..
If you want to see a demo, head over to the financial segments of AAPL